Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but ...
Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...
Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but ...
So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our ...
A team of researchers at The University of Texas at Austin and the University of Porto have created a new way to target ...
CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...
Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, ...
Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.